Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.
作者信息
Cavalli F, Sonntag R, Brunner K W
出版信息
Br Med J. 1975 Oct 25;4(5990):227. doi: 10.1136/bmj.4.5990.227.
Abstract
摘要
相似文献
1
Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.信函：表鬼臼毒素VP 16213治疗急性非淋巴细胞白血病
Br Med J. 1975 Oct 25;4(5990):227. doi: 10.1136/bmj.4.5990.227.
2
[The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].[采用新型细胞抑制剂组合治疗急性髓细胞白血病首次复发期]
Schweiz Med Wochenschr. 1976 Sep 18;106(38):1265-8.
3
Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.信函：表鬼臼毒素VP 16213治疗急性非淋巴细胞白血病
Br Med J. 1975 Feb 15;1(5954):396. doi: 10.1136/bmj.1.5954.396.
4
Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.长春花生物碱（长春新碱、长春地辛）和表鬼臼毒素（依托泊苷）对小鼠骨髓性白血病的比较作用
Br J Cancer. 1987 May;55(5):517-9. doi: 10.1038/bjc.1987.105.
5
Acute myelomonocytic leukemia in a dog.一只狗患急性粒单核细胞白血病。
J Am Vet Med Assoc. 1983 Jan 15;182(2):137-41.
6
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
Schweiz Med Wochenschr. 1975 Oct 18;105(42):1365-9.
7
VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.依托泊苷（VP - 16 - 213）联合环磷酰胺、阿霉素、长春新碱及强的松治疗非霍奇金淋巴瘤。
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1135-7.
8
[Therapy of acute leukemias].[急性白血病的治疗]
Schweiz Med Wochenschr. 1973 Sep 22;103(38):1310-4.
9
[Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].[成人急性髓细胞白血病的治疗；1968年至1975年的情况]
Ned Tijdschr Geneeskd. 1977 Nov 12;121(46):1843-7.
10
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
Cancer Clin Trials. 1980;3(4):325-8.
引用本文的文献
1
[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].依托泊苷（VP 16-213）——一种具有高抗肿瘤活性的鬼臼毒素衍生物（作者译）
Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212.
2
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.
Cancer Chemother Pharmacol. 1989;23(6):373-6. doi: 10.1007/BF00435839.
3
Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide.使用包含阿糖胞苷、柔红霉素和依托泊苷的方案对新诊断的急性髓细胞白血病进行诱导化疗。
Cancer Chemother Pharmacol. 1990;26(5):380-2. doi: 10.1007/BF02897299.
4
Podophyllotoxin derivative VP 16-213.鬼臼毒素衍生物VP 16 - 213
Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976.
本文引用的文献
1
Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.环磷酰胺（NSC - 26271）、长春新碱（NSC - 67574）、阿糖胞苷（NSC - 63878）和泼尼松（NSC - 10023）（COAP）联合化疗用于成人急性白血病。
Cancer Chemother Rep. 1972 Aug;56(4):543-50.
Zotero 插件